Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity

Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity

US Patent 12383566 · Granted Aug 12, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiot2021
Cardiomyocytes from induced pluripotent stem cells from patients and methods of 2016
Chemically defined production of cardiomyocytes from pluripotent stem cells2016